ethiopian pharmaceuticals supply agency · 2020. 9. 18. · ethiopian pharmaceuticals supply agency...
TRANSCRIPT
-
Ethiopian Pharmaceuticals Supply Agency
Tender Management Directorate Annual Procurement Plan 2013/2014 EFY
Prepared by
Prepared by
Seifu Isa, Director, Tender Management, EPSA
Dan Victor Ojwando, Senior Technical Advisor, Procurement
and Contracts Management (Global)
Solomon Berhie Tekle, National Technical Advisor,
Procurement and Contracts
April 2020
April 2020
-
Forward
This document is an annual procurement plan of the Ethiopian Pharmaceuticals
Supply Agency for the 2013 Ethiopian Fiscal Year which defines the appropriate goods
(pharmaceuticals products, lab chemical and reagents and medical equipment) that
the agency will obtain from local and international suppliers.
The purpose of the document is to inform the list of required goods, to estimate the
forecasted expenses and to define the tendering procedures and implementation
timelines. This procurement plan helps the agency define its procurement
requirements and to decide where and when to procure.
Consistent with the Federal Public Procurement Proclamation 649/2009 Chapter
Three-Section 22, Public bodies shall have to prepare an annual procurement plan
showing their procurement for the concerned budget year and containing such
details are stated in the directive to be issued by the Minister.
The procurement plan shall have to be approved by the head of the public body
concerned and communicated to the relevant departments of the public body and the
Agency until Hamle 30 of the Ethiopian Calendar.
In light of fairness and transparency the procurement plans shall be published and
made available to the general public. Through publication of the Procurement Plans,
interested bidders can be made aware of the upcoming tenders and thus have ample
time to prepare themselves accordingly.
By publishing the plans, the public is also made aware of the different activities to be
undertaken by the agency within the specified year and in turn it gives a clearer
picture of public spending.
Goitom Gigar
Inbound Deputy Director General
-
Acknowledgement
The Ethiopian Pharmaceuticals Supply Agency (EPSA) would like to acknowledge all
contributors for their effort in developing this annual procurement plan for 2013 EFY.
The agency further expresses its immense appreciations to PSA staff for their
workforce capacity support to ensure this plan to success with the required quality.
The agency would like to extend its gratitude once again to Pamela Steele Associates
(PAS) under the Admas program for their professional, technical, and financial
support throughout the development of this document.
Finally, the agency would also like to thank to the following persons who contributed
a lot to this Procurement plan:
- Mr.Goitom Gigar, Inbound Deputy Director General, EPSA
- Mr. Seifu Isa, Tender Management Directorate, EPSA
- Mr. Tibebu Hailu, Tender Management Medicine Program Coordinator, EPSA
- Mr. Abyot Adane, Tender Management Medicine Revolving Drug Fund
Coordinator, EPSA
- Mr. Walta Tekle, Tender Management Medical Equipment Coordinator, EPSA
- Ms. Hilina Tesfaye, Tender Management Chemical and Medical Supplies
Coordinator, EPSA
- Mr. Abrahale Beyene, Tender Management Medical Equipment Officer, EPSA
- Mr. Teketel Ahadu, Tender Management Medicine Program Officer, EPSA
- Mr. Damtew Negash, Tender Management Chemical and Medical Supplies
officer, EPSA
- Mr. Dan Oluoch, Procurement Technical Advisor, PSA
- Mr. Solomon Berhie Tekle, Procurement Technical Advisor, PSA
-
Abbreviation
EFY Ethiopian Fiscal Year
EPSA Ethiopian Supply Agency
DDG Deputy Director General
PPP Public Procurement Plan
PSA Pamela Steele Associates
RDF Revolving Drug Fund
SDP Service Delivery Point
-
Table of Contents Introduction ............................................................................................................................................ 6
Background ............................................................................................................................................. 6
Advantage of the procurement plan ...................................................................................................... 7
Objectives ............................................................................................................................................... 8
Scope ....................................................................................................................................................... 8
Purpose ................................................................................................................................................... 8
Legal Framework that supports Annual procurement planning ............................................................. 9
Source of Funds ....................................................................................................................................... 9
Supply Plan and Budget Allocation ......................................................................................................... 9
Procurement Method and their applications ......................................................................................... 9
Activities ............................................................................................................................................ 10
Challenges and mitigation measures .................................................................................................... 11
Risk Management ................................................................................................................................. 11
Special Procurement Methods ............................................................................................................. 18
Large Value Procurement ................................................................................................................. 18
Procedure of Framework Contract ................................................................................................... 18
Publication of Annual Procurement Plan .............................................................................................. 19
Conclusions ........................................................................................................................................... 20
-
Introduction
The Procurement Plan is an annual document which defines the products and
services that a Public Body will obtain from external suppliers. A sound procurement
plan helps a Procuring Entity to define their procurement requirements and to decide
what, when where and how to procure.
EPSA being a public institution, its procurement and contract management is
governed by procurement legal frameworks (Proclamation 649/2009, Directive 8th
June 2010 and Manual 2011) issued by PPA. Tender management directorate must
ensure total compliance with the provisions and conditions of the legal frameworks.
Annual Procurement planning is one of the critical process that each public
Institution is required to undertake to ensure annually the needs to sustain their
operations are planned through annual procurement planning processes. This
process must be aligned with available resource to ensure delivery of required
services to general public. Tender management always ensure proper planning of
requirements for EPSA to ensure that EPSA constantly delivers services expected of
them by the government and the general public. Procurement planning at EPSA is a
complex process that requires proper and advance planning since it involves so
many stakeholders internally and externally that relies a lot on EPSA services.
Tender management therefore must work very closely with the key stakeholders to
ensure annual procurement planning processes is achieved and necessary
approvals granted before implementation of the plan.
Background Pursuant to section 22 of Proclamation 649/2009 and section 8 (Part III) of the
Directive June 2010 on procurement planning provides for the following.
1) Public bodies shall have to prepare an annual procurement plan showing
their procurement for the concerned budget year and containing such
details as are stated in the directive to be issued by the Minister.
2) The procurement plan to be prepared by public bodies in accordance with
sub-article (1) of this Article, shall have to be approved by the head of the
public body concerned and communicated to the relevant departments of
the public body and the Agency until Hamle 30 of the Ethiopian Calendar.
-
3) Any Public Body and other entities accountable to such Public Body shall be
required to prepare a procurement plan supported by action plan enabling
them to execute in due time, the procurement necessary to implement their
work program.
In view of the above conditions, tender management directorate
commenced annual procurement planning for EPSA requirements for
financial year 2013. This process was commenced through a workshop in
Adama with all key stakeholder present to ensure the objectives of the
workshop is achieved. The workshop focused on review of legal
frameworks to a certain the condition and provisions of the same,
documentation used for planning as provided by the legal frameworks and
risk identification associated with the planning processes & mitigation
measures.
Advantage of the procurement plan
The advantages of the procurement planning process are as follows:
• Strong alignments and cooperation with key stakeholders
• Economies of scale are gained by uniting the requirements of different
areas to achieve better deals
• There are no surprises when requirements manifest
• Everyone can plan and schedule resources more effectively.
• Periodic indicative notices can be published based on the procurement
plan
• The procurement plan is linked to the strategic plan of the agency
-
Objectives Pursuant to section 8 (Part III) of the Directive June 2010 on procurement planning
provides for the following.
1. The procurement plan shall be prepared in such a way as to enable the
attainment of the following objectives: -
a) To ensure compliance with principles of public procurement stated in
article 5 of the Proclamation.
b) To achieve the work program of the Public Body.
c) To ensure economy and efficiency in the operation of the Public Body by
discouraging piecemeal purchase.
d) Exercise prudence and make the necessary preparation to forestall
problems that might be encountered in the execution of procurement.
EPSA Tender management directorate will ensure that the stated objectives
are achieved during development and implementation of the annual
procurement planning.
Scope The annual procurement planning will focus on procurement of Medical Supplies,
Laboratory Reagents & Chemicals, Medicines and Medical Equipment’s for both RDF
and Program items. All the items under RDF must in the approved EPSA procurement
list consideration with National Essential Medicine List and items for stock.
Program commodities and capital medical equipment annual forecast and plan will
be done in collaborations with Ministry of Health and stakeholders respectively.
Purpose The main purpose of the annual procurement planning process is to ensure all
requirements from all key stakeholders are properly planned for and acquired during
the financial year for respective use and increase coordination of service delivery at
all SDP’s by ensure constant supply of Medical commodities.
-
Legal Framework that supports Annual procurement planning EPSA being a public institution within the Federal Government its procurement
processes are governed by the following legal frameworks:
Proclamation 649/2009
Directive June 2010
Manual 2011
Financial Management Act (Proclamation 648/2009), (970/2016)
Audit & Governance Act (Proclamation No 649/2010), (982/2016)
Tender Management team must ensure total compliance with provisions and
conditions of the state legal frameworks during annual procurement planning and
implementation without breach.
Source of Funds The procurement of all health commodities in view of EPSA Procurement List will be
based on the following sources of funds:
Revolving Drug Fund (RDF): This will focus on stock items where EPSA
warehouse and distribute at a cost recovery through mark ups.
Program Based Fund: This focus on non-stock items-based service
oriented in line with donor program requirements which EPSA stock
and distribute for free.
Supply Plan and Budget Allocation Tender management adopted items for annual procurement planning based upon
approved supply plan with proper budget, right procurement items in compliance
with procurement list and required approval from respective EPSA management.
Procurement Method and their applications Pursuant to section 15 (Part IV) of the Directive June 2010 on methods of procurement
to be used during planning provides for the following.
15.1 The following procurement methods are approved as per article 33 of the
Proclamation.
-
a) Open bidding
b) Restricted bidding
c) Request for quotations
d) Single source/ direct procurement
e) Request for proposal, and
f) Two stage bidding
15.2 Except as otherwise provided in the Proclamation and this Directive, public
bodies shall use
open bidding as the preferred procedure of procurement.
15.3 Public bodies may use a method other than open bidding only where
conditions for use
of such other method stipulated in the Proclamation and this Directive are
satisfied.
15.4 A Public Body using a method of procurement other than open bidding
pursuant to article
33/3 of the Proclamation. Shall record a statement of the grounds and
circumstances on
which it relied to justify the use of that method.
Activities A. Individual Plans from each coordinator
B. Consolidated Procurement (RDF & Program)
C. Implementation Plan
D. Risk Management Plan
1. Approval and Amendment of procurement plan, consolidated plan,
implementation plan & risk mitigation plan
Pursuant to section 8 (Part III) of the Directive June 2010 on approval and amendment
of procurement planning provides for the following.
1. Procurement units of public bodies have to submit the annual procurement
plan they
have prepared to the head of the Public Body for approval after consultation
with the Procurement Endorsing Committee of the Public Body.
2. The head of a Public Body has to monitor the execution of procurement by
establishing a
system enabling him to ascertain that the conduct of procurement
conforms to the approved procurement plan.
-
3. The head of a Public Body shall send a copy of the approved annual
procurement plan to
the appropriate departments and the Agency for implementation and follow
up in accordance with the provision of article 22/2 of the proclamation.
4. Public Body shall not split procurements nor deviate from the annual
procurement plan once it is approved by the head of the Public Body and a
copy of it is sent to the Agency.
5. Notwithstanding the provision of sub article 4 of this article, a Public Body
may at any time modify its procurement plan where necessary.
6. A procurement plan modified in accordance with sub article 5 of this article
shall be sent to those departments and the Agency for which the initial
procurement plan was sent.
In view of the above conditions, each coordinator will ensure their
respective plans are ready, examined by Director Procurement, cleared by
Deputy Director General inbound, Reviewed by Tender Endorsement
committee and approved by Director General. Tender Management will only
implement approved annual procurement plan that has been endorsed by
EPSA Executive Committee and Board of Directors.
Challenges and mitigation measures
Registration
Un planned procurement requests
Complaint
Foreign currency
Custom and bank, and another stakeholder’s cooperativeness
Global scenario API price shoot
Risk Management
Risk Possible
Consequences Possible Solutions
Critical procurement activity
Failure to secure accurate
information or data at the
Demand and Supply Planning.
Failure to achieve
key organizational
results
Develop market knowledge
Identify alternative sources
and extra due diligences to
-
Total costs of
procurement too high
check he capacity of
suppliers
Plan in advanced
Work closely with
beneficiary/ partner to be
aware of rapid changes of
needs
Apply contractual penalties
and remedies
Selection of procurement Strategy
Selection of inappropriate
procurement strategy
Inadequate or
inappropriate results
Not achieving best
value for money
Damage procurement
implementation
Agree on desired
outcomes/objectives and
have a clear understanding
of the project objectives
Develop a good
understanding of
associated risks in order to
incorporate them into
procurement strategies
development
Planning
Lack of planning
Delay in task
implementation
Inadequate supplier
response
Procurement
process shortcuts
Higher prices
Early involvement of
procurement officers in
project planning
Develop and communicate
an accurate Requisition
Plan
Insufficient lead-time
Inadequate supplier
response
Procurement
process shortcuts
Higher prices
Involve procurement
officers in the project
planning phase
-
Delay requisitions to create false
emergencies
Claims of unethical
or unfair dealings
Delay of project
implementation
Higher total cost of
acquisition
Not achieving Best
Value for Money
Early involvement of
procurement officers in
project implementation
Seek proper justification of
emergencies
Training of requisitioners
Requirements definition
Restrictive
specifications/TOR/SOW
Inadequate suppliers’
response
Limits competition
Lack of transparency
Developed market and
product understanding
Include generic functional
and performance
specifications
Apply relevant international
standards where applicable
Inadequate
specifications/TOR/SOW
Significant variety in
offers received
Insufficient
responses
Offer of
goods/services that
do not meet needs
Difficulty in
evaluating competing
offers
Become familiar with
requirements of the
specification/TOR/SOW
Developed market and
product understanding
External support
(consultant) to developed
specifications/TOR/ SOW
linked to clear deliverables
and target time
Do not include quality
requirements in
specifications/TOR/SOW
Impossibility to
achieve best value
for money
Difficulty in
comparison and
overall evaluation
Poor quality of the
procured items,
which may lead to a
waste of funds
Include quality in the
specifications/TOR/SOW,
using international and
national standards
If quality is a critical issue,
extra due diligence must be
used (i.e., check
manufacturing process and
standards, factory visits,
sampling and independent
-
laboratory analysis, pre-
shipment inspection, etc.)
Sourcing
Wrong approach to market
Inadequate or
inappropriate
supplier response
Higher prices
Selection of
inappropriate
approach
Analyse supply market
Develop sourcing
strategies
Identify wrong sourcing strategy
or do not have sourcing strategy
Inadequate or
inappropriate
supplier response
Limit competition
Proper application of the
pre-qualification or post-
qualification, depending on
the identified complexity
and risk
Misrepresentation of facts by
potential suppliers
Contract with
unsuitable
companies
Claims of unethical
or unfair dealing
Breach of contract
Independently verify
suppliers’ qualifications
Conduct supplier reference
check and due diligences
Outdated information on potential
suppliers
Inadequate suppliers’
response
Limit competition
Maintain suppliers’ roster
Advertisement of procurement
notices in inappropriate media
Lack of sourcing
strategy
Limit competition
Contract with
unsuitable
companies
Identify relevant media to
post procurement notices
Preparation and issuance of Bid documents
Use of inappropriate evaluation
criteria
Inadequate or
inappropriate results
Have clear goal to be
achieved as a result of the
procurement process
-
Not achieving best
value for money
Re-tendering (time/
cost)
Consider implications of
evaluation criteria
Unacceptable requirements to
suppliers
Loading the cost in
offers
Limits competition
Too few bids
Re-tendering
(time/cost)
Develop strong
understanding of market
and industry practices
Develop commercially
acceptable terms
Check that responsibility
for risks is not allocated to
suppliers for factors
outside their control
Provisions of inadequate
information
Loading cost in offers
Great variation in
offers
Create confusion
among potential
suppliers
Re-tendering
(time/cost)
Review documents before
issue
Know the market
Receipt and Evaluation
Failure to observe effective
evaluation procedures
Lack of fair
treatment of
suppliers
Inconsistency in
evaluation of offers
Subjectivity in
outcome of the
evaluations
Composition of the
evaluation team in line with
the project scope and
complexities
For high tech/highly
complex procurement
activities, ensure technical
expertise
Ensure staff are suitably
trained and experienced
Failure of offers to meet project
needs Need to re-tender
Ensure that specifications
are understandable,
generic, and in line with
what exists in the market
-
Know the marketplace
Failure of evaluation to identify a
clear winner, leading to
subjective discussions or
development of “new criteria”
Claims of unethical
and unfair behaviour
Need to re-tender
Ensure that selection
criteria are appropriate and
aligned with the project
needs
Selection of inappropriate
supplier
Failure of the
supplier to fulfil the
contract
Waste of funds
Contract disputes
Re-tendering
(time/cost)
Reject offers from
unacceptable suppliers and
document rationale for the
rejection
Develop clear evaluation
criteria aligned with the
project needs
Perform technical and
financial checks on
suppliers before awarding
the contract
Select inappropriate goods/
service
Failure of
goods/services to
meet the project
needs
Waste of funds
Re-tendering
(time/cost)
Develop proper
specifications/ TOR/SOW
Have the right technical
expertise during the
evaluation process
Ensure users are involved
Insufficient number of responses
Need to start the
procurement again
Delays to
procurement
schedule
Lack of value for
money due to limited
competition
Develop strong
understanding of market
Foster international
competition
Develop supplier rosters
Allow for sufficient time for
suppliers to prepare offers
Procurement Review and Award
Contract approval not obtained
Delay in the contract
award
Need to re-bid
(time/cost)
Proper procurement risk
analysis
-
Undermine business
community trust
Proper procurement
strategies (including
sourcing strategies)
Market understanding
Proper procurement
planning
Clear, generic and
complete
specifications/TOR/ SOW
Foster international
competition
Ensure adherence
throughout process to
rules, regulations and
procedures
Ensure adequate
documentation of process
and submission
Contract management
Unstructured or non-existent
contract management function
Not achieving best
value for money
Poor performance of
suppliers
Delivery delays
Possible cost
variation
Contract disputes
Identify resources for
contract managements
Develop structures for
contract management,
including clear roles and
responsibilities
Identify the right profile and
competences for contract
management
Develop contract
management plans
Failure by either party to fulfil the
conditions of the contract
Contract disputes
Failure or partial
failure to satisfy the
project needs
Delays
Legal actions
Ensure proper contract
management
Contract monitoring,
including regular
inspections and progress
reports
-
Review past performance
records
Be proactive
Maintain accurate records
and documentations
Special Procurement Methods Pursuant to section 60, 61& 63 of Proclamation 649/2009 (Chapter Eleven) on special
procurement Methods provides for the following.
Large Value Procurement
1) There shall be established a central body, which shall be in charge of the execution of large value procurements having national significance procurements of supplies for which a demand is shown by more than one public body and sale of public property to be disposed of, by a regulation to be issued by the Council of Ministers.
2) The Minister shall identify and update the types of procurements to be executed on account of their national significance by the central body which shall be established pursuant to sub article (1) of this Article.
Procedure of Framework Contract
1) Framework contracts may be used to fulfil similar procurement requirements
of various
Public bodies or recurrent procurement requirements of a public body.
2) The following procedure of framework contract shall be followed to meet similar
procurement requirements of public bodies within a given time frame:
a) the Agency shall undertake a survey of the similar requirements of public
bodies, issue a list of goods and services constituting such requirements
and update the list regularly.
b) public bodies shall prepare a forecast of their requirements of goods and
services falling under the list mentioned in sub-article (2) (a) of this
Article and communicate the same to the body authorized to conduct
large procurements.
c) the body to be established in accordance with Article 60(1) of this
Proclamation shall conclude and administer framework contracts in the
manner prescribed herein and the directive to be issued by the Ministry.
d) public bodies shall base on the framework contract signed by the central
body of procurement conclude the procurement by making order with the
suppliers of goods and services that they require.
-
e) the order that public bodies place with the suppliers for goods and
services of their requirements under the framework contract shall
confirm to the terms of the framework contract regarding price, terms of
payment and other matters related to the execution of procurement.
3) Except in cases provided for in Article 37 paragraph (k) of this Proclamation,
public bodies shall not be allowed to vary unit prices and such other
fundamental terms of the framework contract when placing order for goods
and services. However, the public body and the supplier may agree on terms
that have not been dealt with in the framework contract or that do not
materially affect the framework contract.
4) The framework contract shall be awarded through open bidding procedure and
may remain valid for three years.
5) In procuring goods and services under a framework contract to fulfill their
recurrent requirements, public bodies shall have to adhere to the criterion of
fixing prices of goods and services to be determined in the directive to be
issued by the Minister.
Tender management directorate in view of the above, will adopt both methods and
deploy based on the conditions outlined above, currently TMD is undertaking both
large volume and framework agreements approach under strategic sourcing
requirements. Framework agreement and large volume has proved to enable EPSA
start reducing on lead time management and encourage private sector to participate
in procurement process competitively thus improving on health commodity
availability and affordability.
Publication of Annual Procurement Plan Pursuant to section 8 (Part III) of the Directive June 2010 on approval and amendment
of procurement planning provides for the following.
The Agency may compile the annual procurement plans submitted to it by public
bodies in accordance with article 13/3 of this Directive, and as necessary, publish
procurement plans the value of which exceed the threshold specified in article 6/5 of
this Directive by assorting such plans by type of procurement, or facilitate the use by
public bodies of its website to post such procurement plans.
In compliance with the provision above, Tender management directorate will publish
the approved procurement plan in accordance with the provisions above. TMD will
not only comply to legal framework provisions but also ensure constant
communication to PPA and public on the plan is achieved.
-
2. Value preposition of annual procurement plan
Conclusions
This procurement plan helps to define the list of the required products that the agency
is going to purchase with a clear implementation plans in lined with the public
procurement proclamation 649/2009 to ensure the good procurement principles and
practices.
-
RDF Health Commodities
Every year EPSA collects health commodities demand from health facilities, the demand information will be conducted and processed through its hubs. The
collected data further analysed and correlated with the stock on hand, on pipelines and past consumption records, this succeed with quantification exercise
for the upcoming year.
Similarly, the annual procurement plan of 2013 E.C. is prepared after passing through a series discussions, cross checking, and consultations. Following the
annual procurement plan, some the commodities will be refilled from the signed framework agreement.
Other commodities will be procured pertinent to their market nature i.e. if there are only one manufacture the solicitation will be done through direct
contracting and if the commodities are available on local market with additional supply the award will be determined after nationally competing the local
bidders. Notwithstanding the above preconditions the selection of bidder will be done through floating in international tender.
Based on the above scenarios the RDF health commodities annual procurement plan for the Ethiopian FY is provided in the below table.
-
Annex 1. RDF commodities Pharmaceuticals Procurement Request (May 2020)
S/
N
o
Co
de
Goods, Services and
Works to be
Procured
Unit Quanti
ty
Curr
ency
Unit
Price
in
USD
Total
price
Source of Budget for
procurement
Procur
ement
Catego
ry*
Estimated
Budget for
Procuremen
t **
Selecte
d
Procur
ement
Metho
d ***
Estimated time
to Procure
Trea
sury
Inte
rnal
Reve
nue
Lo
an
A
id
Recu
rrent
Cap
ital
From
Purcha
se
reques
t up to
signed
Contra
ct Sent
to
CMD
From
Recei
ving
Signe
d
Contr
act up
to
Recei
ving
of
Good
s
1 2 3 4 5 6
7.00
8.00 9 10 11 12 13 14 15 16 17 18
1 Sali-11
Acetylsalicylic Acid - 81mg - Tablet (Enteric Coated)
20x10
71,373
USD
0.82
58,262.65
RDF Medicines
ICB 140 Days
110 Dyas
2 Acyc-32
Acyclovir - 500mg - Powder for injection
Each
2,633 USD
2.99
7,872.67
RDF Medicines
ICB 140 Days
110 Dyas
3 Alpr-11
Alprazolam - 0.5mg – Tablet
10x3
1,159
USD
0.86
990.95
RDF Medicines
ICB 140 Days
110 Dyas
4 Alms-21
Aluminium Hydroxide + Magnesium Hydroxide + Simethicone - (225mg + 200mg + 50mg)/5ml – Suspension
200ml
1,093,2
50
USD
0.64
701,197.6
5 RDF
Medicines
ICB 140 Days
110 Dyas
-
5 Amit-11
Amitriptyline - 25mg – Tablet
25x10
147,12
5 USD
0.82
120,642.5
0 RDF
Medicines
ICB 140 Days
110 Dyas
6 Amox-21
Amoxicillin - 250mg/5ml - Oral Suspension
100ml
2,023,6
20 USD
0.53
1,082,588
.26 RDF
Medicines
ICB 140 Days
110 Dyas
7 Amox-2
Amoxicillin - 500mg – Capsule
50X10
324,51
6 USD
11.96
3,881,351
.61 RDF
Medicines
ICB 140 Days
110 Dyas
8
Amcl-30
Amoxicillin + Clavulanic Acid - (500mg + 100mg) in Vial- Powder for Injection 10
4,934
USD
5.51
27,186.34
RDF Medicines
ICB 140 Days
110 Dyas
9 Ampi-21
Ampicillin - 250mg/5ml - Oral Suspension
100ml
144,83
8 USD
0.54
77,695.99
RDF Medicines
ICB 140 Days
110 Dyas
10 Ampi-02
Ampicillin - 500mg – Capsule
50X10
58,975
USD
15.27
900,771.4
9 RDF
Medicines
ICB 140 Days
110 Dyas
11 Ampi-31
Ampicillin Sodium - 500mg in Vial - Injection
50
128,196 USD
3.03
387,795.4
6 RDF
Medicines
ICB 140 Days
110 Dyas
12 Cfce-60
Anti-haemorrhoidal (Hydrocortisone + Framycetin+ Cinchocaine + Esculoside) - (5mg + 10mg + 5mg ) - Suppository
10
45,954
USD
1.37
62,956.98
RDF Medicines
ICB 140 Days
110 Dyas
13 Aten-11
Atenolol - 50mg – Tablet
10x10
25,378
USD
0.80
20,346.44
RDF Medicines
ICB 140 Days
110 Dyas
14 Ator-12
Atorvastatin - 40mg – Tablet
10x3
103,031 USD
5.56
572,522.6
6 RDF
Medicines
ICB 140 Days
110 Dyas
-
15 Atro-30
Atropine Sulfate - 1mg/ml in 1ml ampoule - Injection
10x10
20,000
USD
6.76
135,296.0
0 RDF
Medicines
ICB 140 Days
110 Dyas
16 Azel-51
Azelaic Acid - 20% - Cream
30gm
13,615 USD
5.35
72,777.62
RDF Medicines
ICB 140 Days
110 Dyas
17 Azit-20
Azithromycin - 200mg/5ml - Oral Suspension
15ml
75,302 USD
0.36
27,289.44
RDF Medicines
ICB 140 Days
110 Dyas
18 Azit-11
Azithromycin - 500mg – Tablet
10x3
135,354 USD
2.56
347,178.9
1 RDF
Medicines
ICB 140 Days
110 Dyas
19 Becp-41
Beclomethasone Dipropionate - 100mcg/dose - Aerosol (Oral Inhalation)
200 Me-
tered dose
42,874
USD
1.76
75,458.24
RDF Medicines
ICB 140 Days
110 Dyas
20 Besa-56
Benzoic Acid + Salicylic Acid - (6% + 3%) - Topical Ointment
20gm
220,884 USD
0.38
83,715.50
RDF Medicines
ICB 140 Days
110 Dyas
21 Betd-50
Betamethasone Dipropionate - 0.03% - Cream
15gm
131,647 USD
0.58
75,697.03
RDF Medicines
ICB 140 Days
110 Dyas
22 calg-30
Calcium gluconate - 10% in 10ml Ampoule - Injection
10
10,624 USD
0.87
9,232.26
RDF Medicines
ICB 140 Days
110 Dyas
23 Cast-20
Castor oil – Liquid 60ml
62,033 USD
0.85
52,455.10
RDF Medicines
ICB 140 Days
110 Dyas
24 Ceft-30
Ceftazidime - 0.5g in Vial - Powder for injection
Each
50,906 USD
0.30
15,373.61
RDF Medicines
ICB 140 Days
110 Dyas
25 Cefr-31
Ceftriaxone - 0.5g in Vial - Powder for Injection with 5ml Diluent
Each
358,515
USD
0.15
53,777.25
RDF Medicines
ICB 140 Days
110 Dyas
-
26 Amph-42
Chloramphenicol - 0.5% - Eye/Ear drop
10ml
198,000 USD
0.29
57,420.00
RDF Medicines
ICB 140 Days
110 Dyas
27 amde-40
Chloramphenicol - 0.5% + Dexamethasone 0.1% - Eye Drop
10ml
208,259
USD
0.24
50,315.37
RDF Medicines
ICB 140 Days
110 Dyas
28 Phen-20
Chlorpheniramine Maleate - 2mg/5ml - Syrup
100ml
169,57
9 USD
0.21
35,221.56
RDF Medicines
ICB 140 Days
110 Dyas
29 Phen-11
Chlorpheniramine Maleate - 4mg - Tablet
10x10
69,190
USD
0.55
38,124.44
RDF Medicines
ICB 140 Days
110 Dyas
30 Cpzn-13
Chlorpromazine Hydrochloride - 100mg - Tablet
100x10
12,852
USD
6.93
89,025.71
RDF Medicines
ICB 140 Days
110 Dyas
31 Cpzn-11
Chlorpromazine Hydrochloride - 25mg - Tablet
1000
8,685 USD
5.69
49,374.50
RDF Medicines
ICB 140 Days
110 Dyas
32 Cpzn-30
Chlorpromazine Hydrochloride - 25mg/2ml in 2ml Ampoule - Injection
50
6,227 USD
5.47
34,038.03
RDF Medicines
ICB 140 Days
110 Dyas
33 Cime-31
Cimetidine - 100mg/ml in 2ml ampoule - Injection
10
525,087 USD
0.76
396,440.6
9 RDF
Medicines
ICB 140 Days
110 Dyas
34 Cime-11
Cimetidine - 400mg – Tablet
10x10
129,59
9 USD
1.72
222,770.3
6 RDF
Medicines
ICB 140 Days
110 Dyas
35 Cipr-10
Ciprofloxacin - 250mg – Tablet
10x10
59,374
USD
1.22
72,701.59
RDF Medicines
ICB 140 Days
110 Dyas
36 Cipr-11
Ciprofloxacin - 500mg – Tablet
10x10
689,24
0 USD
2.09
1,443,560
.80 RDF
Medicines
ICB 140 Days
110 Dyas
-
37 Cist-30
Cisatracurium- 2mg/ml in 10 ml Ampoule - Injection
Each
6,362 USD
11.02
70,128.33
RDF Medicines
ICB 140 Days
110 Dyas
38 Clot-62
Clotrimazole - 500mg - Tablet (Vaginal)
6
3,776 USD
0.30
1,140.35
RDF Medicines
ICB 140 Days
110 Dyas
39 Clox-21
Cloxacillin Sodium - 250mg/5ml - Oral Suspension
100ml
330,37
9 USD
0.54
178,671.2
3 RDF
Medicines
ICB 140 Days
110 Dyas
40 Clox-02
Cloxacillin Sodium - 500 mg – Capsule
50X10
178,70
1 USD
14.72
2,630,974
.53 RDF
Medicines
ICB 140 Days
110 Dyas
41 Cloz-12
Clozapine - 100mg – Tablet
10x5
3,708 USD
7.31
27,099.55
RDF Medicines
ICB 140 Days
110 Dyas
42 Dexa-10
Dexamethasone - 0.5mg – Tablet
10x10
239,03
0 USD
3.74
895,119.5
4 RDF
Medicines
ICB 140 Days
110 Dyas
43 Dext-22
Dextromethorphan Hydro bromide - 15mg/5ml - Syrup
125ml
636,12
7 USD
0.40
253,148.1
5 RDF
Medicines
ICB 140 Days
110 Dyas
44 DW40-34
Dextrose - 40% in 20ml - Intravenous Infusion
50
122,717 USD
2.25
276,126.3
1 RDF
Medicines
ICB 140 Days
110 Dyas
45 Dime-11
Dimenhydrinate - 50mg – Tablet
10x10
18,180
USD
2.05
37,334.45
RDF Medicines
ICB 140 Days
110 Dyas
46 Diph-20
Diphenhydramine Hydrochloride - 12.5mg/5ml - Elixir
125ml
584,65
1 USD
0.28
163,631.2
4 RDF
Medicines
ICB 140 Days
110 Dyas
47 Doxy-01
Doxycycline - 100mg – Capsule
20x10
257,79
8 USD
2.30
592,023.1
3 RDF
Medicines
ICB 140 Days
110 Dyas
48 Enal-12
Enalapril Maleate - 10mg - Tablet
10x10
391,50
1 USD
1.87
733,046.4
7 RDF
Medicines
ICB 140 Days
110 Dyas
-
49 Enal-11
Enalapril Maleate - 5mg – Tablet
10x10
234,56
7 USD
1.24
290,228.8
4 RDF
Medicines
ICB 140 Days
110 Dyas
50 Eryt-20
Erythromycin - 125 mg/5 ml - Oral Suspension
100ml
27,000
USD
1.39
37,508.40
RDF Medicines
ICB 140 Days
110 Dyas
51 Eryt-11
Erythromycin Stearate - 500mg – Tablet
10x10
51,899
USD
5.54
287,300.5
8 RDF
Medicines
ICB 140 Days
110 Dyas
52 Heam-20
Ferrics Ammonium Citrate+ Folic Acid + Cyanocobalamin+ Cupric sulfate + Manganese sulfate - (160mg+0.5mg+7.5mcg+30mcg+30mcg) /5ml- Syrup
100ml
96,546
USD
2.43
234,606.7
8 RDF
Medicines
ICB 140 Days
110 Dyas
53 Fesu-11
Ferrous Sulfate - 325mg – Tablet
10x10
22,528
USD
0.66
14,777.58
RDF Medicines
ICB 140 Days
110 Dyas
54 Fesu-25
Ferrous Sulfate - 75mg/0.6ml - Oral Drop
30ml
10,214 USD
0.10
1,024.36
RDF Medicines
ICB 140 Days
110 Dyas
55 Conf-12
Fluconazole - 200mg – Tablet
10x10
23,435 USD
2.63
61,606.33
RDF Medicines
ICB 140 Days
110 Dyas
56 Fuci -50
Fluocinolone Acetonide - 0.025% - Cream
10gm
79,998 USD
0.29
22,972.78
RDF Medicines
ICB 140 Days
110 Dyas
57 Fluo -01
Fluoxetine - 20mg – Capsule
10x2
137,495 USD
0.59
81,172.74
RDF Medicines
ICB 140 Days
110 Dyas
58 Foli-13
Folic Acid - 5mg – Tablet
10x10
21,969 USD
3.46
76,089.55
RDF Medicines
ICB 140 Days
110 Dyas
59 Frus-11
Furosemide - 40mg – Tablet
10x10
133,47
9 USD
0.78
104,290.8
1 RDF
Medicines
ICB 140 Days
110 Dyas
-
60 Glib-10
Glibenclamide - 5mg – Tablet
10x10
365,72
6 USD
0.52
191,922.8
2 RDF
Medicines
ICB 140 Days
110 Dyas
61 Gris-11
Griseofulvin - 250mg – Tablet
10x10
47,549
USD
3.10
147,164.1
6 RDF
Medicines
ICB 140 Days
110 Dyas
62 Guai-20
Guaifenesin - 100mg/5ml – Syrup
100ml
143,22
8 USD
0.40
57,833.03
RDF Medicines
ICB 140 Days
110 Dyas
63 Hald-30
Haloperidol Decanoate - 50mg/ml in 1ml Ampoule - Injection (Depot, oily)
5
4,725 USD
6.49
30,679.43
RDF Medicines
ICB 140 Days
110 Dyas
64 Halo-45
Halothane – Inhalation 250m
l
18,156 USD
15.00
272,340.0
0 RDF
Medicines
ICB 140 Days
110 Dyas
65 Thia-11
Hydrochlorothiazide - 25mg – Tablet
10x10
329,87
6 USD
0.75
248,123.9
6 RDF
Medicines
ICB 140 Days
110 Dyas
66 Cort-56
Hydrocortisone Acetate - 1% - Topical Ointment
15gm
340,951 USD
0.39
134,191.1
9 RDF
Medicines
ICB 140 Days
110 Dyas
67 Hyos-11
Hyoscine (Scopolamine) Butyl bromide - 10mg - Tablet
10x10
46,300
USD
3.20
148,076.4
2 RDF
Medicines
ICB 140 Days
110 Dyas
68 Ibup-12
Ibuprofen - 400mg – Tablet
10x10
519,35
0 USD
0.99
514,192.9
3 RDF
Medicines
ICB 140 Days
110 Dyas
69 Icht-56
Ichthammol - 10% - Topical Ointment
20gm
78,458 USD
0.35
27,448.38 RDF
Medicines
ICB 140 Days
110 Dyas
70 Indo-01
Indomethacin - 25mg – Capsule
10x10
175,20
5 USD
1.16
203,040.1
4 RDF
Medicines
ICB 140 Days
110 Dyas
-
71 Keto-50
Ketoconazole - 2% - Cream
20gm
395,703 USD
0.27
106,839.8
1 RDF
Medicines
ICB 140 Days
110 Dyas
72 Keto-10
Ketoconazole - 200mg – Tablet
10x10
29,383
USD
1.86
54,653.14
RDF Medicines
ICB 140 Days
110 Dyas
73 Lora-10
Loratadine - 10mg - Tablet
10x10
31,979
USD
1.15
36,779.87
RDF Medicines
ICB 140 Days
110 Dyas
74 Mebe-20
Mebendazole - 100mg/5ml - Oral Suspension
30ml
405,224 USD
0.16
66,157.86
RDF Medicines
ICB 140 Days
110 Dyas
75 Metf-10
Metformin - 500mg – Tablet
10x10
418,60
2 USD
0.87
363,554.9
7 RDF
Medicines
ICB 140 Days
110 Dyas
76 Dopm-10
Methyldopa - 250mg – Tablet 100x
10
4,913
USD
28.70
141,003.1
0 RDF
Medicines
ICB 140 Days
110 Dyas
77 Pram-20
Metoclopramide - 0.2mg/drop - Oral Drop
15ml
287,980 USD
0.39
113,342.9
2 RDF
Medicines
ICB 140 Days
110 Dyas
78 Pram-11
Metoclopramide - 10mg - Tablet
10x10
79,651
USD
0.22
17,416.09
RDF Medicines
ICB 140 Days
110 Dyas
79 Pram-21
Metoclopramide - 5mg/5ml – Syrup
60ml
150,959 USD
0.40
59,634.36
RDF Medicines
ICB 140 Days
110 Dyas
80 Metr-20
Metronidazole - 125mg/5ml - Oral Suspension
100ml
1,081,8
54 USD
0.32
346,944.1
9 RDF
Medicines
ICB 140 Days
110 Dyas
81 Metr-01
Metronidazole - 250mg – Capsule
100x10
119,57
9 USD
6.73
804,616.6
3 RDF
Medicines
ICB 140 Days
110 Dyas
82 Muvi-20
Multivitamin - Syrup 120m
l
150,14
3 USD
0.42
63,060.06
RDF Medicines
ICB 140 Days
110 Dyas
-
83 Nife-12
Nifedipine - 20mg – Tablet
10x10
264,21
0 USD
0.77
203,353.4
1 RDF
Medicines
ICB 140 Days
110 Dyas
84 Norf-10
Norfloxacin - 400mg – Tablet
10x10
111,42
0 USD
2.18
243,235.6
8 RDF
Medicines
ICB 140 Days
110 Dyas
85 Omep-02
Omeprazole - 20 mg - Capsule (Enclosing Enteric Coated Granules)
10x10
867,95
4 USD
0.85
736,356.2
6 RDF
Medicines
ICB 140 Days
110 Dyas
86 Omep-30
Omeprazole - 4mg/ml in 10ml – Injection
Each
386,088 USD
1.09
419,754.8
7 RDF
Medicines
ICB 140 Days
110 Dyas
87 Orsp-26
Oral Rehydration Salt - 20.7g for 1 Litre Preparation - Powder
Sachet
2,747,9
91 USD
0.06
157,025.3
1 RDF
Medicines
ICB 140 Days
110 Dyas
88 Para-20
Paracetamol - 120mg/5ml – Syrup
60ml
1,620,000 USD
0.22
349,498.2
6 RDF
Medicines
ICB 140 Days
110 Dyas
89 Para-13
Paracetamol - 500mg – Tablet
100x10
171,35
1 USD
4.37
749,335.2
9 RDF
Medicines
ICB 140 Days
110 Dyas
90 Pent-30
Pentazocine - 30mg/ml in 1 ampoule - Injection
10
1,062 USD
12.17
12,925.18
RDF Medicines
ICB 140 Days
110 Dyas
91 Perm-55
Permethrin - 0.05 – Cream
30gm
112,292 USD
0.42
47,477.06
RDF Medicines
ICB 140 Days
110 Dyas
92 Barb-13
Phenobarbitone (Phenobarbital) - 100mg - Tablet
100x10
45,642
USD
7.14
325,742.4
5 RDF
Medicines
ICB 140 Days
110 Dyas
93 Barb-11
Phenobarbitone (Phenobarbital) - 30mg - Tablet
1000
12,466 USD
3.06
38,106.04
RDF Medicines
ICB 140 Days
110 Dyas
-
94 Hyda-36
Phenytoin (Diphenhydantoin) Sodium - 250mg - Powder for injection
Each
6,812 USD
2.84
19,337.91
RDF Medicines
ICB 140 Days
110 Dyas
95 Pipe-22
Piperazine Citrate - 700mg/5ml – Elixir
29ml
133,031 USD
0.12
16,172.87
RDF Medicines
ICB 140 Days
110 Dyas
96 Pred-13
Prednisolone - 5 mg – Tablet
100x10
23,018
USD
8.31
191,247.3
8 RDF
Medicines
ICB 140 Days
110 Dyas
97 Prom-10
Promethazine HCL - 25mg – Tablet
100x10
6,576
USD
5.39
35,467.60
RDF Medicines
ICB 140 Days
110 Dyas
98 Prom-20
Promethazine HCL - 5mg/5ml – Elixir
100ml
20,251
USD
0.82
16,512.67
RDF Medicines
ICB 140 Days
110 Dyas
99 Prtu-12
Propylthiouracil - 100mg - Tablet (Scored)
100
129,206 USD
8.42
1,088,174
.24 RDF
Medicines
ICB 140 Days
110 Dyas
100
Rani-10
Ranitidine - 150mg – Tablet
10x10
15,409 USD
1.22
18,867.83
RDF Medicines
ICB 140 Days
110 Dyas
101
Salb-10
Salbutamol (Albuterol) - 2mg – Tablet
10x10
57,730
USD
0.52
30,042.64
RDF Medicines
ICB 140 Days
110 Dyas
102
Salb-20
Salbutamol (Albuterol) - 2mg/5ml - Syrup
100ml
117,62
8 USD
0.28
32,578.61
RDF Medicines
ICB 140 Days
110 Dyas
103
Sert-11
Sertraline HCL - 100mg – Tablet
10x10
2,736
USD
10.60
29,002.15
RDF Medicines
ICB 140 Days
110 Dyas
104
Snak-30
Snake Venom Antiserum Polyvalent - Injection 10ml
13,518
USD
34.80
470,426.4
0 RDF
Medicines
ICB 140 Days
110 Dyas
105
Socr-40
Sodium Cromoglycate - 2% - Eye Drop
10ml
21,230 USD
0.38
8,067.40
RDF Medicines
ICB 140 Days
110 Dyas
-
106
Stib-30
Sodium Stibogluconate - 33% W/V - Injection
100ml
1,915 USD
8.15
15,614.91
RDF Medicines
ICB 140 Days
110 Dyas
107
Sodb-30
Sodium Bicarbonate - 8.4%w/v in 25ml ampoule- Injection 50
1,134
USD
163.47
185,374.9
8 RDF
Medicines
ICB 140 Days
110 Dyas
108
Valp-10
Sodium Valproate - 200mg - Tablet (enteric coated)
10x10
153,20
8 USD
2.07
317,140.5
6 RDF
Medicines
ICB 140 Days
110 Dyas
109
Sutr-20
Sulphamethoxazole + Trimethoprim - (200mg +40mg)/5ml - Suspension
100ml
1,132,4
14 USD
0.30
335,096.2
4 RDF
Medicines
ICB 140 Days
110 Dyas
110
Sutr-11
Sulphamethoxazole + Trimethoprim - (400mg +80mg) - Tablet
100x10
32,324
USD
8.45
273,005.8
0 RDF
Medicines
ICB 140 Days
110 Dyas
111
Sulp-51
Sulphur - 10% - Ointment
50gm
489,929 USD
0.38
188,540.8
1 RDF
Medicines
ICB 140 Days
110 Dyas
112
Tini-10
Tinidazole - 500 mg – Tablet
60x4
63,392
USD
3.15
199,684.8
0 RDF
Medicines
ICB 140 Days
110 Dyas
113
Cain-40
Tetracaine - 0.5% - Eye Drop
10ml
8,537 USD
1.45
12,375.24
RDF Medicines
ICB 140 Days
110 Dyas
114
Epth-10
Theophylline + Ephedrine - (120mg + 11mg) - Tablet
100x10
12,754
USD
5.08
64,847.19
RDF Medicines
ICB 140 Days
110 Dyas
115
Vbbb-10
Vitamin B1 + Vitamin B6 + Vitamin B12 - (100mg +200mg + 1000mcg) - Tablet
10x10
199,67
4 USD
2.55
509,168.7
0 RDF
Medicines
ICB 140 Days
110 Dyas
116
Vbbb-30
Vitamin B1 + Vitamin B6 + Vitamin B12 -
3
93,952
USD
0.45
42,654.21
RDF Medicines
ICB 140 Days
110 Dyas
-
(100mg +100mg +1000mcg) - Injection
117
Wars-11
Warfarin Sodium - 5mg – Tablet
10x10
40,059
USD
2.53
101,349.2
7 RDF
Medicines
ICB 140 Days
110 Dyas
118
Wate-31
Water For Injection - 10ml – Injection
100
36,847 USD
1.76
64,701.34
RDF Medicines
ICB 140 Days
110 Dyas
119
Petr-56
White Petrolatum – Ointment
50gm
102,73
0 USD
0.41
42,119.30
RDF Medicines
ICB 140 Days
110 Dyas
120
Petr-57
White Petrolatum – Ointment
1Kg
9,897 USD
6.56
64,920.88
RDF Medicines
ICB 140 Days
110 Dyas
121
Zinc-50
Zinc Oxide 15% Cream 20gm
125,424 USD
0.50
62,710.90
RDF Medicines
ICB 140 Days
110 Dyas
122
Sali-14
Acetylsalicylic Acid - 300mg - Tablet (Micro fined)
10x10
337,20
3 ETB
13.14
4,429,498
.61 RDF
Medicines
NCB 90 days 110 Dyas
123
Sali-11
Acetylsalicylic Acid - 81mg - Tablet (Enteric Coated)
20x10
71,373
ETB
28.00
1,998,444
.00 RDF
Medicines
NCB 90 days 110 Dyas
124
Acyc-10
Acyclovir - 200mg – Capsule
10x10
13,937
ETB
63.46
884,387.8
1 RDF
Medicines
NCB 90 days 110 Dyas
125
Albe-20
Albendazole - 100mg/5ml - Oral Suspension
20ml
470,907 ETB
6.40
3,013,804
.80 RDF
Medicines
NCB 90 days 110 Dyas
126
Albe-11
Albendazole - 400mg – Tablet
50x2
76,001 ETB
80.47
6,115,800
.47 RDF
Medicines
NCB 90 days 110 Dyas
127
Alms-21
Aluminium Hydroxide + Magnesium Hydroxide + Simethicone - (225mg
200ml
1,093,2
50 ETB
22.00
24,051,50
0.00 RDF
Medicines
NCB 90 days 110 Dyas
-
+ 200mg + 50mg)/5ml – Suspension
128
Alma-10
Aluminium Hydroxide + Magnesium Trisilicate - (120mg + 250mg) - Tablet (Chewable)
100x10
27,629
ETB
126.10
3,484,016
.90 RDF
Medicines
NCB 90 days 110 Dyas
129
Amox-21
Amoxicillin - 250mg/5ml - Oral Suspension
100ml
2,023,6
20 ETB
18.35
37,133,42
7.00 RDF
Medicines
NCB 90 days 110 Dyas
130
Amox-2
Amoxicillin - 500mg – Capsule
50X10
324,51
6 ETB
410.25
133,132,6
89.00 RDF
Medicines
NCB 90 days 110 Dyas
131
Ampi-21
Ampicillin - 250mg/5ml - Oral Suspension
100ml
144,83
8 ETB
18.40
2,665,019
.20 RDF
Medicines
NCB 90 days 110 Dyas
132
Ampi-02
Ampicillin - 500mg – Capsule
50X10
58,975
ETB
523.90
30,897,00
2.50 RDF
Medicines
NCB 90 days 110 Dyas
133
Aten-11
Atenolol - 50mg – Tablet
10x10
25,378
ETB
27.50
697,895.0
0 RDF
Medicines
NCB 90 days 110 Dyas
134
Ator-11
Atorvastatin - 20mg – Tablet
10x10
67,732
ETB
150.00
10,159,80
0.00 RDF
Medicines
NCB 90 days 110 Dyas
135
Azit-11
Azithromycin - 500mg – Tablet
10x3
135,354 ETB
87.98
11,908,44
4.92 RDF
Medicines
NCB 90 days 110 Dyas
136
Besa-56
Benzoic Acid + Salicylic Acid - (6% + 3%) - Topical Ointment
20gm
220,884 ETB
13.00
2,871,492
.00 RDF
Medicines
NCB 90 days 110 Dyas
137
Phen-11
Chlorpheniramine Maleate - 4mg - Tablet
10x10
69,190
ETB
18.90
1,307,691
.00 RDF
Medicines
NCB 90 days 110 Dyas
-
138
Cpzn-13
Chlorpromazine Hydrochloride - 100mg - Tablet
100x10
12,852
ETB
237.60
3,053,635
.20 RDF
Medicines
NCB 90 days 110 Dyas
139
Cpzn-11
Chlorpromazine Hydrochloride - 25mg - Tablet
1000
8,685 ETB
195.00
1,693,575
.00 RDF
Medicines
NCB 90 days 110 Dyas
140
Cime-11
Cimetidine - 400mg – Tablet
10x10
129,59
9 ETB
58.96
7,641,157
.04 RDF
Medicines
NCB 90 days 110 Dyas
141
Cipr-10
Ciprofloxacin - 250mg – Tablet
10x10
59,374
ETB
42.00
2,493,708
.00 RDF
Medicines
NCB 90 days 110 Dyas
142
Cipr-11
Ciprofloxacin - 500mg – Tablet
10x10
689,24
0 ETB
71.84
49,515,00
1.60 RDF
Medicines
NCB 90 days 110 Dyas
143
Clox-21
Cloxacillin Sodium - 250mg/5ml - Oral Suspension
100ml
330,37
9 ETB
18.55
6,128,530
.45 RDF
Medicines
NCB 90 days 110 Dyas
144
Clox-02
Cloxacillin Sodium - 500 mg – Capsule
50X10
178,70
1 ETB
505.00
90,244,00
5.00 RDF
Medicines
NCB 90 days 110 Dyas
145
Dext-22
Dextromethorphan Hydro bromide - 15mg/5ml - Syrup
125ml
636,12
7 ETB
13.65
8,683,133
.55 RDF
Medicines
NCB 90 days 110 Dyas
146
DW40-34
Dextrose - 40% in 20ml - Intravenous Infusion
50
122,717 ETB
77.18
9,471,298
.06 RDF
Medicines
NCB 90 days 110 Dyas
147
Diph-20
Diphenhydramine Hydrochloride - 12.5mg/5ml - Elixir
125ml
584,65
1 ETB
9.60
5,612,649
.60 RDF
Medicines
NCB 90 days 110 Dyas
148
Doxy-01
Doxycycline - 100mg – Capsule
20x10
257,79
8 ETB
78.77
20,306,74
8.46 RDF
Medicines
NCB 90 days 110 Dyas
149
Enal-11
Enalapril Maleate - 5mg – Tablet
10x10
234,56
7 ETB
42.44
9,955,023
.48 RDF
Medicines
NCB 90 days 110 Dyas
-
150
Eryt-11
Erythromycin Stearate - 500mg – Tablet
10x10
51,899
ETB
189.88
9,854,582
.12 RDF
Medicines
NCB 90 days 110 Dyas
151
Heam-20
Ferrics Ammonium Citrate+ Folic Acid + Cyanocobalamin+ Cupric sulfate + Manganese sulfate - (160mg+0.5mg+7.5mcg+30mcg+30mcg) /5ml- Syrup
100ml
96,546
ETB
83.20
8,032,627
.20 RDF
Medicines
NCB 90 days 110 Dyas
152
Fesu-11
Ferrous Sulfate - 325mg – Tablet
10x10
22,528
ETB
22.50
506,880.0
0 RDF
Medicines
NCB 90 days 110 Dyas
153
Fesu-25
Ferrous Sulfate - 75mg/0.6ml - Oral Drop
30ml
10,214 ETB
3.44
35,136.16
RDF Medicines
NCB 90 days 110 Dyas
154
Conf-12
Fluconazole - 200mg – Tablet
10x10
23,435
ETB
90.17
2,113,133
.95 RDF
Medicines
NCB 90 days 110 Dyas
155
Fuci -50
Fluocinolone Acetonide - 0.025% - Cream
10gm
79,998 ETB
9.85
787,980.3
0 RDF
Medicines
NCB 90 days 110 Dyas
156
Fluo -01
Fluoxetine - 20mg – Capsule
10x2
137,495 ETB
20.25
2,784,273
.75 RDF
Medicines
NCB 90 days 110 Dyas
157
Foli-13
Folic Acid - 5mg – Tablet
10x10
21,969
ETB
118.80
2,609,917
.20 RDF
Medicines
NCB 90 days 110 Dyas
158
Frus-11
Frusemide - 40mg – Tablet
10x10
133,47
9 ETB
26.80
3,577,237
.20 RDF
Medicines
NCB 90 days 110 Dyas
159
Glib-10
Glibenclamide - 5mg – Tablet
10x10
365,72
6 ETB
18.00
6,583,068
.00 RDF
Medicines
NCB 90 days 110 Dyas
-
160
Gris-10
Griseofulvin - 125mg – Tablet
10x10
23,402
ETB
57.70
1,350,295
.40 RDF
Medicines
NCB 90 days 110 Dyas
161
Gris-20
Griseofulvin - 125mg/5ml - Oral Suspension
100ml
11,000
ETB
46.31
509,410.0
0 RDF
Medicines
NCB 90 days 110 Dyas
162
Guai-20
Guaifenesin - 100mg/5ml – Syrup
100ml
143,22
8 ETB
13.85
1,983,707
.80 RDF
Medicines
NCB 90 days 110 Dyas
163
Thia-11
Hydrochlorothiazide - 25mg – Tablet
10x10
329,87
6 ETB
25.80
8,510,800
.80 RDF
Medicines
NCB 90 days 110 Dyas
164
Cort-56
Hydrocortisone Acetate - 1% - Topical Ointment
15gm
340,951 ETB
13.50
4,602,838
.50 RDF
Medicines
NCB 90 days 110 Dyas
165
Hyos-11
Hyoscine (Scopolamine) Butyl bromide - 10mg - Tablet
10x10
46,300
ETB
109.70
5,079,110
.00 RDF
Medicines
NCB 90 days 110 Dyas
166
Ibup-12
Ibuprofen - 400mg – Tablet
10x10
519,35
0 ETB
33.96
17,637,12
6.00 RDF
Medicines
NCB 90 days 110 Dyas
167
Icht-56
Ichthammol - 10% - Topical Ointment
20gm
78,458 ETB
12.00
941,496.0
0 RDF
Medicines
NCB 90 days 110 Dyas
168
Indo-01
Indomethacin - 25mg – Capsule
10x10
175,20
5 ETB
39.75
6,964,398
.75 RDF
Medicines
NCB 90 days 110 Dyas
169
Keto-10
Ketoconazole - 200mg – Tablet
10x10
29,383
ETB
63.80
1,874,635
.40 RDF
Medicines
NCB 90 days 110 Dyas
170
Lora-10
Loratadine - 10mg - Tablet
10x10
31,979
ETB
39.45
1,261,571
.55 RDF
Medicines
NCB 90 days 110 Dyas
-
171
Mebe-10
Mebendazole - 100mg – Tablet
40x6
59,152 ETB
46.70
2,762,398
.40 RDF
Medicines
NCB 90 days 110 Dyas
172
Mebe-20
Mebendazole - 100mg/5ml - Oral Suspension
30ml
405,224 ETB
5.60
2,269,254
.40 RDF
Medicines
NCB 90 days 110 Dyas
173
Metf-10
Metformin - 500mg – Tablet
10x10
418,60
2 ETB
29.79
12,470,15
3.58 RDF
Medicines
NCB 90 days 110 Dyas
174
Sali-56
Methyl salicylate - 25% - Ointment
20gm
116,560 ETB
11.70
1,363,752
.00 RDF
Medicines
NCB 90 days 110 Dyas
175
Pram-20
Metoclopramide - 0.2mg/drop - Oral Drop
15ml
287,980 ETB
13.50
3,887,730
.00 RDF
Medicines
NCB 90 days 110 Dyas
176
Pram-11
Metoclopramide - 10mg - Tablet
10x10
79,651
ETB
7.50
597,382.5
0 RDF
Medicines
NCB 90 days 110 Dyas
177
Pram-21
Metoclopramide - 5mg/5ml – Syrup
60ml
150,959 ETB
13.55
2,045,494
.45 RDF
Medicines
NCB 90 days 110 Dyas
178
Metr-20
Metronidazole - 125mg/5ml - Oral Suspension
100ml
1,081,8
54 ETB
11.00
11,900,39
4.00 RDF
Medicines
NCB 90 days 110 Dyas
179
Metr-01
Metronidazole - 250mg – Capsule
100x10
119,57
9 ETB
230.80
27,598,83
3.20 RDF
Medicines
NCB 90 days 110 Dyas
180
Nife-12
Nifedipine - 20mg – Tablet
10x10
264,21
0 ETB
26.40
6,975,144
.00 RDF
Medicines
NCB 90 days 110 Dyas
181
Norf-10
Norfloxacin - 400mg – Tablet
10x10
111,42
0 ETB
74.88
8,343,129
.60 RDF
Medicines
NCB 90 days 110 Dyas
-
182
Omep-02
Omeprazole - 20 mg - Capsule (Enclosing Enteric Coated Granules)
10x10
867,95
4 ETB
29.10
25,257,46
1.40 RDF
Medicines
NCB 90 days 110 Dyas
183
Orsp-26
Oral Rehydration Salt - 20.7g for 1 Litre Preparation - Powder
Sachet
2,747,9
91 ETB
1.96
5,386,062
.36 RDF
Medicines
NCB 90 days 110 Dyas
184
Para-20
Paracetamol - 120mg/5ml – Syrup
60ml
1,620,000 ETB
7.40
11,988,00
0.00 RDF
Medicines
NCB 90 days 110 Dyas
185
Para-13
Paracetamol - 500mg – Tablet
100x10
171,35
1 ETB
150.00
25,702,65
0.00 RDF
Medicines
NCB 90 days 110 Dyas
186
Barb-13
Phenobarbitone (Phenobarbital) - 100mg - Tablet
100x10
45,642
ETB
244.80
11,173,16
1.60 RDF
Medicines
NCB 90 days 110 Dyas
187
Barb-11
Phenobarbitone (Phenobarbital) - 30mg - Tablet
1000
12,466 ETB
104.85
1,307,060
.10 RDF
Medicines
NCB 90 days 110 Dyas
188
Pipe-22
Piperazine Citrate - 700mg/5ml – Elixir
29ml
133,031 ETB
4.17
554,739.2
7 RDF
Medicines
NCB 90 days 110 Dyas
189
Pred-13
Prednisolone - 5 mg – Tablet
100x10
23,018
ETB
284.99
6,559,899
.82 RDF
Medicines
NCB 90 days 110 Dyas
190
Prom-10
Promethazine HCL - 25mg – Tablet
100x10
6,576
ETB
185.00
1,216,560
.00 RDF
Medicines
NCB 90 days 110 Dyas
191
Prtu-12
Propylthiouracil - 100mg - Tablet (Scored)
100
129,206 ETB
288.88
37,325,02
9.28 RDF
Medicines
NCB 90 days 110 Dyas
192
Rani-10
Ranitidine - 150mg – Tablet
10x10
15,409
ETB
42.00
647,178.0
0 RDF
Medicines
NCB 90 days 110 Dyas
-
193
Ring-31
Ringer's Solution - Each contains Na+ 147mEq + K+4mEq Cl-155mEq - Intravenous Infusion with Giving Set
1000ml
1,872,4
82
ETB
24.40
45,688,56
0.80 RDF
Medicines
NCB 90 days 110 Dyas
194
Salb-10
Salbutamol (Albuterol) - 2mg – Tablet
10x10
57,730
ETB
17.85
1,030,480
.50 RDF
Medicines
NCB 90 days 110 Dyas
195
Salb-20
Salbutamol (Albuterol) - 2mg/5ml - Syrup
100ml
117,62
8 ETB
9.50
1,117,466
.00 RDF
Medicines
NCB 90 days 110 Dyas
196
Sodc-33
Sodium Chloride (Normal Saline) - 0.009 - Intravenous Infusion with Giving Set
1000ml
6,912,5
06 ETB
20.40
141,015,1
22.40 RDF
Medicines
NCB 90 days 110 Dyas
197
Sutr-20
Sulphamethoxazole + Trimethoprim - (200mg +40mg)/5ml - Suspension
100ml
1,132,4
14 ETB
10.15
11,494,00
2.10 RDF
Medicines
NCB 90 days 110 Dyas
198
Sutr-11
Sulphamethoxazole + Trimethoprim - (400mg +80mg) - Tablet
100x10
32,324
ETB
289.70
9,364,262
.80 RDF
Medicines
NCB 90 days 110 Dyas
199
Sulp-51
Sulphur - 10% - Ointment
50gm
489,929 ETB
13.20
6,467,062
.80 RDF
Medicines
NCB 90 days 110 Dyas
200
Tini-10
Tinidazole - 500 mg – Tablet
60x4
63,392
ETB
108.00
6,846,336
.00 RDF
Medicines
NCB 90 days 110 Dyas
201
Epth-10
Theophylline + Ephedrine - (120mg + 11mg) - Tablet
100x10
12,754
ETB
174.40
2,224,297
.60 RDF
Medicines
NCB 90 days 110 Dyas
202
Wate-31
Water For Injection - 10ml – Injection
100
36,847 ETB
60.23
2,219,294
.81 RDF
Medicines
NCB 90 days 110 Dyas
-
203
Petr-56
White Petrolatum – Ointment
50gm
102,73
0 ETB
14.00
1,438,220
.00 RDF
Medicines
NCB 90 days 110 Dyas
204
Petr-57
White Petrolatum – Ointment
1Kg
9,897 ETB
225.00
2,226,825
.00 RDF
Medicines
NCB 90 days 110 Dyas
205
Zinc-50
Zinc Oxide 15% Cream 20
gm
125,42
4 ETB
17.15
2,151,021
.60 RDF
Medicines
NCB 90 days 110 Dyas
206
Azol-11
Acetazolamide - 250mg – Tablet
10x10
6,534 USD
2.65
17,315.10
RDF Medicines
Framework
35-45 Days
110 Days
207
Adre-30
Adrenaline (Epinephrine) - 0.1% in 1ml ampoule –Injection
Each
839,207
USD
0.50
419,603.5
0 RDF
Medicines
Framework
35-45 Days
110 Days
208
Amcl-20
Amoxicillin + Clavulanic Acid - (125mg +31.25mg)/5ml - Oral Suspension
100ml
247,49
4 USD
0.67
164,583.5
1 RDF
Medicines
Framework
35-45 Days
110 Days
209
Amcl-14
Amoxicillin + Clavulanic Acid - (500mg + 125mg) - Tablet (Film Coated)
5x3
1,435,570
USD
0.83
1,184,345
.25 RDF
Medicines
Framework
35-45 Days
110 Days
210
Amcl-12
Amoxicillin + Clavulanic Acid - 250mg + 125mg - Tablet (Film Coated)
10x2
131,831
USD
0.98
129,589.8
7 RDF
Medicines
Framework
35-45 Days
110 Days
211
Bepl-55
Anti-haemorrhoidal (Betamethasone Valer- ate + Phenylephrine HCl + Lidocaine HCl) - (0.5mg+1mg+25mg) – Ointment
20gm
135,142
USD
0.60
80,814.92
RDF Medicines
Framework
35-45 Days
110 Days
-
212
Betd-56
Betamethasone Dipropionate - 0.05% - Ointment
20gm
60,122 USD
0.45
27,054.90
RDF Medicines
Framework
35-45 Days
110 Days
213
Bupi-32
Bupivacaine 0.5% in 10ml injection
5
71,581 USD
3.00
214,743.0
0 RDF
Medicines
Framework
35-45 Days
110 Days
214
Carb-20
Carbamazepine - 100mg/5ml – Syrup
100ml
3,945
USD
3.13
12,347.85
RDF Medicines
Framework
35-45 Days
110 Days
215
Carb-11
Carbamazepine - 200mg – Tablet
10x10
86,707
USD
4.08
353,764.5
6 RDF
Medicines
Framework
35-45 Days
110 Days
216
Cefe-31
Cefepime - 1gm in Vial - Powder for Injection with Solvent Water for Injection*
Each
59,019
USD
0.56
33,050.64
RDF Medicines
Framework
35-45 Days
110 Days
217
Cefr-32
Ceftriaxone - 1g in vial - Powder for Injection with 10ml Diluent
Each
6,762,807 USD
0.19
1,255,853
.26 RDF
Medicines
Framework
35-45 Days
110 Days
218
Ceph-20
Cephalexin - 125mg/5ml - Oral Suspension
100ml
266,11
4 USD
0.38
101,123.3
2 RDF
Medicines
Framework
35-45 Days
110 Days
219
Ceti-11
Cetirizine - 10mg - Tablet
10x10
17,047 USD
0.36
6,171.01
RDF Medicines
Framework
35-45 Days
110 Days
220
Cipr-40
Ciprofloxacin - 0.3% - Eye/Ear drop
5ml
114,757 USD
0.11
12,623.27
RDF Medicines
Framework
35-45 Days
110 Days
221
Dexa-40
Dexamethasone - 0.10% - Eye/Ear drop
10ml
239,030 USD
0.20
46,849.88
RDF Medicines
Framework
35-45 Days
110 Days
222
Fesu-20
Ferrous Sulfate - 125mg/5ml – Syrup
200ml
32,400
USD
0.40
12,960.00
RDF Medicines
Framework
35-45 Days
110 Days
223
Fusi-50
Fusidic Acid - 2% - Topical Cream
10g